Article
Epigenenomic and transcriptomic characterization of <i>NPM1</i> -mutated CN-AML subtypes
2024-05-10
Abstract excerpt
<h4>ABSTRACT</h4> Cytogenetic normal AML with NPM1 mutations forms a distinct AML entity, associated with an intermediate prognosis and a heterogeneous response to treatment. We previously described an epigenetic biomarker, defined by the level of H3K27me3 on 70kb of the HIST1 cluster in patient blast DNA. This epigenetic mark separates cytogenetically normal NPM1 mut AML into two groups of patients differing...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93fea0e7-6f0e-5418-bfb1-15cdb40105c4
- DOI
- 10.1101/2024.05.07.592738
